hydroxyamphetamine hydrobromide

hydroxyamphetamine hydrobromide (PAREDRINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

PAREDRINE is a marketed brand name for hydroxyamphetamine hydrobromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

hydroxyamphetamine hydrobromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.